微信平台糖尿病推文准确性及其影响因素分析

Accuracy and influencing factors of diabetes-related subscriptions on the WeChat platform

目的了解微信平台糖尿病相关推文的阅读传播现状,并对准确性及其影响因素进行分析。方法以“糖尿病”为关键词检索新榜《2020年中国微信公众号年榜》中排名前100位微信公众号的推文,检索时限均从2021年6月1日至2021年8月31日。推文准确性评价基于是否与现行临床实践指南一致,由2位专科医师独立进行。采用SPSS 22.0软件进行统计分析。结果共纳入26个微信公众号发布的68篇糖尿病相关推文,其中25篇(36.8%)与现行临床实践指南不一致。与指南不一致推文的每千次阅读“在看”数、每千次阅读“点赞”数均高于指南一致推文,差异具有统计学意义(P<0.05)。有专家支持(80.8%vs.52.4%)和证据支持(91.7%vs.57.1%)的推文与临床实践指南的一致率较无专家支持和证据支持的推文高。涉及商业推广(16.7%vs.67.7%)的推文一致率较不涉及商业推广的推文低。结论糖尿病相关推文在微信公众号上有一定的传播能力,但部分内容与现行临床实践指南推荐意见不一致,读者更倾向为不一致推文点击“在看”或“点赞”。微信平台糖尿病推文的撰写和发布需要专家和证据支持,商业推广的途径应进一步规范。

Objective To analyze the current state,evaluate the accuracy,and determine the influencing factors of diabetes-related subscriptions on the WeChat platform.Methods The top 100 WeChat platforms on the"China WeChat Platform New Rank Annual List 2020"were searched using the term"diabetes".We identified diabetes-related subscriptions published from June 1,2021 to August 31,2021.The accuracy of subscriptions was analyzed according to the consistency with clinical practice guidelines,and was independently assessed by two specialists.SPSS 22.0 software was used for data analysis.Results Sixty-eight subscriptions from 26 WeChat platforms were included.Twenty-five(36.8%)subscriptions were evaluated as inconsistent.The numbers of"wow"per thousand reads and"like"per thousand reads of inconsistent diabetic subscriptions were statistically higher than those of consistent diabetic subscriptions(P<0.05).Subscriptions with expert support(80.8%vs.52.4%)and evidence support(91.7%vs.57.1%)shared a higher consistency(P<0.05).Subscriptions with commercial promotion(16.7%vs.67.7%)had a lower consistency(P=0.02).Conclusion Although some content is inconsistent with guidelines,diabetes-related subscriptions have a certain dissemination ability on the WeChat platform.Moreover,readers are more likely to"wow"or"like"for inconsistent subscriptions.Diabetesrelated subscriptions on the WeChat public platform need supervision and can be further regulated by providing evidence support and regulating commercial promotion.